Strides Pharma Science Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Strides Pharma Science Limited has informed the stock exchanges that its trading window will remain closed from April 1, 2026 until 48 hours after the company declares its financial results for the quarter and full year ended March 31, 2026. This is a routine compliance measure taken under SEBI's Insider Trading Regulations and the company's own code of conduct to prevent insiders from trading while in possession of unpublished price-sensitive information. The date of the board meeting to approve the Q4 and FY26 financial results has not yet been disclosed and will be communicated later. The intimation has been signed by Manjula Ramamurthy, Company Secretary and Compliance Officer.
This is a standard regulatory filing and does not carry any direct financial impact for shareholders. Investors should note that company insiders, promoters and designated persons will be restricted from trading in the stock during the closed window, which is a routine practice ahead of earnings announcements.